Cargando…

Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes

IMPORTANCE: Identifying the course of demyelinating disease associated with myelin oligodendrocyte glycoprotein (MOG) autoantibodies is critical to guide appropriate treatment choices. OBJECTIVE: To characterize serial anti-MOG antibody serologies and clinical and imaging features at presentation an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waters, Patrick, Fadda, Giulia, Woodhall, Mark, O’Mahony, Julia, Brown, Robert A., Castro, Denise A., Longoni, Giulia, Irani, Sarosh R., Sun, Bo, Yeh, E. Ann, Marrie, Ruth Ann, Arnold, Douglas L., Banwell, Brenda, Bar-Or, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763982/ https://www.ncbi.nlm.nih.gov/pubmed/31545352 http://dx.doi.org/10.1001/jamaneurol.2019.2940

Ejemplares similares

Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria
por: Fadda, Giulia, et al.
Publicado: (2022)

Comparison of Spinal Cord Magnetic Resonance Imaging Features Among Children With Acquired Demyelinating Syndromes
por: Fadda, Giulia, et al.
Publicado: (2021)

Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies
por: Lee, Haeng-Jin, et al.
Publicado: (2018)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
por: Tea, Fiona, et al.
Publicado: (2019)

Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Relapse With COVID-19
por: Woodhall, Mark, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
por: Peschl, Patrick, et al.
Publicado: (2017)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children
por: Hacohen, Yael, et al.
Publicado: (2015)

Physical activity and dentate gyrus volume in pediatric acquired demyelinating syndromes
por: Longoni, Giulia, et al.
Publicado: (2018)

Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination
por: Peschl, Patrick, et al.
Publicado: (2017)

Antibody-mediated biorecognition of myelin oligodendrocyte glycoprotein: computational evidence of demyelination-related epitopes
por: Ierich, Jéssica Cristiane Magalhães, et al.
Publicado: (2019)

MRI-Negative Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Antibody Spectrum Demyelinating Disease
por: Pérez, Carlos A., et al.
Publicado: (2019)

Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS
por: Gerhards, Ramona, et al.
Publicado: (2020)

The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parents
por: O’Mahony, Julia, et al.
Publicado: (2022)

Family health conditions and parental occupational status modify the relationship between pediatric-onset multiple sclerosis and parental health-related quality of life
por: O’Mahony, Julia, et al.
Publicado: (2023)

A surface‐in gradient of thalamic damage evolves in pediatric multiple sclerosis
por: Fadda, Giulia, et al.
Publicado: (2019)

Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report
por: Gil-Perotin, Sara, et al.
Publicado: (2018)

Diagnostic challenges and pitfalls of myelin oligodendrocyte glycoprotein antibody–associated demyelination: Lessons from neuropathology
por: Höftberger, Romana, et al.
Publicado: (2019)

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
por: Höftberger, Romana, et al.
Publicado: (2020)

CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies
por: Zhao-Fleming, Hannah H., et al.
Publicado: (2021)

The gut microbiota in pediatric multiple sclerosis and demyelinating syndromes
por: Tremlett, Helen, et al.
Publicado: (2021)

High rates of health care utilization in pediatric multiple sclerosis: A Canadian population-based study
por: Marrie, Ruth Ann, et al.
Publicado: (2019)

Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease: Our Experience with this Distinct Syndrome
por: Pujari, Shripad S., et al.
Publicado: (2021)

Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes
por: Simone, Marta, et al.
Publicado: (2021)

Patterns of white and gray structural abnormality associated with paediatric demyelinating disorders
por: Bells, Sonya, et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
por: Cross, Helen, et al.
Publicado: (2021)

Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children
por: Longoni, Giulia, et al.
Publicado: (2014)

Stability of the gut microbiota in persons with paediatric-onset multiple sclerosis and related demyelinating diseases
por: Liang, Geoffrey, et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
por: Di Pauli, Franziska, et al.
Publicado: (2018)

Immunoglobulin A Antibodies Against Myelin Oligodendrocyte Glycoprotein in a Subgroup of Patients With Central Nervous System Demyelination
por: Ayroza Galvão Ribeiro Gomes, Ana Beatriz, et al.
Publicado: (2023)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
por: Sechi, Elia, et al.
Publicado: (2022)

Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
por: Hofer, Livia Sophie, et al.
Publicado: (2020)

Clinical characteristics of myelin-oligodendrocyte glycoprotein antibody-positive pediatric autoimmune encephalitis without demyelination: A case series
por: Song, Xiaojie, et al.
Publicado: (2022)

Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom
por: Satukijchai, Chanjira, et al.
Publicado: (2022)

Invasive Multimodality Neuromonitoring to Manage Cerebral Edema in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
por: Fainberg, Nina A., et al.
Publicado: (2023)

Structure and chromosomal localization of the gene for the oligodendrocyte-myelin glycoprotein
Publicado: (1990)

Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis
por: Nakajima, Hideki, et al.
Publicado: (2015)

Limbic Encephalitis with Anti-myelin Oligodendrocyte Glycoprotein Antibody
por: Takasone, Ken, et al.
Publicado: (2020)

Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease
por: Lopez, Joseph A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vugt2qlqv32nqgb7qvgtujcifs